A recent letter to the NEJM gives some pause on Advair. The problem is with the salmeterol component, which can lead to clinical worsening if given during an acute asthma attack.
Related posts:
- Advair: An asthma patient considers the cost
- Clearing the confusion on asthma medications, and why Advair and Symbicort are still safe
- The controversy surrounding asthma and long acting beta agonists
- Acute Wiiitis
- Does using Plavix with a proton pump inhibitor raise the risk of death in heart attack patients?
- How often do doctors ignore drug interaction warnings generated by electronic prescribing systems?
- Drug warnings
KevinMD.com on Facebook
{ 1 comment }
We had this in the UK some weeks ago. See link:
http://www.timesonline.co.uk/article/0,,8122-2287373.html
Obviously the brand names differ, but we’re all talking about the same thing!
The Asthma UK site, published this to reassure people (see link below) because we don’t get it prescribed over here on its own:
http://www.asthma.org.uk/news_media/news/reassurance_1.html
Comments on this entry are closed.